Skip to Content
Merck

Irritable bowel syndrome--diarrhoea.

Best practice & research. Clinical gastroenterology (2013-02-07)
Arnold Wald
ABSTRACT

IBS is a functional gastrointestinal disorder which has been subtyped according to bowel habits. This review presents recommendations for IBS-D which makes up about 1/3 of all patients and which is defined as IBS with loose or watery stools with ≥25% of bowel movements. Because IBS is a complex biopsychosocial illness, treatment cannot and should not be directed only to altered bowel habits. Evidence will be presented for dietary manipulations, probiotics and pharmacotherapies including tricyclic agents, antibiotics, serotonin antagonists and anti-diarrhoeal agents in the management of patients with IBS-D.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Loperamide hydrochloride
Supelco
Loperamide hydrochloride, VETRANAL®, analytical standard
Loperamide hydrochloride for system suitability, European Pharmacopoeia (EP) Reference Standard
Loperamide hydrochloride, European Pharmacopoeia (EP) Reference Standard
Supelco
Loperamide hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material